It has previously been shown that Treg numbers are significantly increased in high-risk MDS, whereas in low-risk MDS IL-17-producing CD4+ T cells were increased, which suggests an association between the number of Treg and Th17 and disease severity [31, 35]. This evidence concerns the gene IL17A and myelodysplastic syndrome.